标题
MicroRNA-192 suppresses liver metastasis of colon cancer
作者
关键词
-
出版物
ONCOGENE
Volume 33, Issue 46, Pages 5332-5340
出版商
Springer Nature
发表日期
2013-11-11
DOI
10.1038/onc.2013.478
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells
- (2012) Neka A K Simms et al. BMC CANCER
- The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis
- (2012) Fanyan Meng et al. CANCER AND METASTASIS REVIEWS
- MiR-93 enhances angiogenesis and metastasis by targeting LATS2
- (2012) Ling Fang et al. CELL CYCLE
- Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144
- (2012) Idoia G. Zubeldia et al. EXPERIMENTAL CELL RESEARCH
- Overcoming Resistance to Antiangiogenic Therapies
- (2012) S. Tejpar et al. ONCOLOGIST
- MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer
- (2012) Shahana Majid et al. PLoS One
- MicroRNA-550a Acts as a Pro-Metastatic Gene and Directly Targets Cytoplasmic Polyadenylation Element-Binding Protein 4 in Hepatocellular Carcinoma
- (2012) Qi Tian et al. PLoS One
- Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion In Vitro
- (2011) C. Kahlert et al. CLINICAL CANCER RESEARCH
- Restoration of Transforming Growth Factor-β Receptor II Expression in Colon Cancer Cells with Microsatellite Instability Increases Metastatic Potentialin Vivo
- (2011) Xiao-Qiong Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
- (2011) Taewan Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX
- (2010) Markus Klinger et al. ANNALS OF SURGICAL ONCOLOGY
- IAP Regulation of Metastasis
- (2010) Swarna Mehrotra et al. CANCER CELL
- Phosphatase PRL-3 Is a Direct Regulatory Target of TGF in Colon Cancer Metastasis
- (2010) Y. Jiang et al. CANCER RESEARCH
- E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-
- (2010) B. Wang et al. DIABETES
- Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy
- (2010) A. Krupa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor β1: a novel role of miR-382
- (2010) Alison J. Kriegel et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro
- (2010) Z Jin et al. ONCOGENE
- Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites
- (2010) Doron Betel et al. GENOME BIOLOGY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
- (2009) Mitsuo Kato et al. NATURE CELL BIOLOGY
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor -Mediated Invasion and Metastasis in Pancreatic Cancer Cells
- (2008) S. Zhao et al. CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started